Do All Women Need Testosterone in Menopause?

This distinction matters clinically. Two women may have identical total testosterone levels, yet experience very different symptoms depending on SHBG levels, estrogen status, metabolic health, and tissue sensitivity. That is why testosterone evaluation should never rely on a single lab value in isolation.

Why Testosterone Becomes a Menopause Topic

Testosterone levels decline gradually with age, and this decline may accelerate during the menopausal transition due to ovarian aging and changes in hormonal signaling. At the same time, women in menopause often experience symptoms such as:

• Reduced sexual desire

• Changes in arousal or sexual responsiveness

• Fatigue

• Loss of muscle tone

• Mood changes

• Reduced sense of vitality

Observational studies have found associations between lower testosterone levels and outcomes such as reduced bone density, increased cardiovascular risk, and higher all-cause mortality in older women. For example, population-based data reviewed by the Endocrine Society notes correlations between androgen levels and musculoskeletal and vascular markers, but emphasizes that these findings do not establish causation.

This distinction is critical. Observational research can highlight patterns, but it cannot prove that testosterone therapy will prevent disease, slow aging, or improve longevity. Randomized controlled trials are required for that — and in women, those trials remain limited.

Where the Evidence Is Strongest: Sexual Desire and Function

The most consistent and well-supported indication for testosterone therapy in women is sexual function, specifically low sexual desire in postmenopausal women diagnosed with hypoactive sexual desire disorder (HSDD).

Multiple randomized controlled trials and meta-analyses demonstrate that physiologic testosterone therapy can improve:

• Sexual desire

• Arousal

• Orgasm

• Sexual satisfaction

• Frequency of satisfying sexual experiences

• Sexual self-image

• Sexual distress

A large meta-analysis published in The Lancet Diabetes & Endocrinology reviewing over 8,000 women found that testosterone therapy significantly improved several domains of sexual function in postmenopausal women compared to placebo, without clear benefits for mood, cognition, or body composition.

This is an important point: testosterone’s benefits appear targeted, not global. It is not a general energy booster or anti-aging hormone.

Testosterone, the Brain, and Sexual Motivation

Testosterone influences regions of the brain involved in motivation, reward, and desire, including limbic structures and hypothalamic pathways. It also interacts with neurotransmitters such as dopamine and serotonin, which play roles in sexual behavior and mood regulation.

However, sexual desire in women is multifactorial. Stress, sleep disruption, relationship dynamics, mental health, caregiving responsibilities, and hormonal fluctuations all interact. Research in premenopausal and perimenopausal women shows inconsistent results, with testosterone sometimes correlating with increased solitary desire but not necessarily improved partnered desire — particularly under high stress conditions.

This supports a core principle in hormone care: testosterone cannot compensate for unmanaged stress, poor sleep, or relationship strain.

Mood and Depression: What Testosterone Can — and Cannot — Do

Testosterone has plausible biological mechanisms for influencing mood, but current human data does not support its routine use for treating depression or mood disorders in menopausal women.

A systematic review published in Menopause evaluated observational studies involving thousands of women and found no consistent association between total testosterone levels and depression in postmenopausal women.

Some studies suggest bioavailable testosterone may be relevant, but the evidence remains inconclusive. At present, testosterone should not be prescribed primarily for mood improvement.

Cognitive Function and Brain Health

Interest in testosterone and cognition has grown, but evidence remains limited. Small experimental studies suggest testosterone may influence certain aspects of spatial processing and memory, but these findings are short-term and not generalizable.

No high-quality clinical trials demonstrate that testosterone therapy improves long-term cognitive function or prevents dementia in women. Major organizations, including the North American Menopause Society, do not recommend testosterone for cognitive enhancement.

Bone Density and Musculoskeletal Health

Testosterone can be aromatized into estrogen, which plays a well-established role in bone health. Observational data shows associations between testosterone levels and bone mineral density, but interventional trials in women have not consistently shown meaningful improvements in bone density or fracture risk.

Resistance training, adequate protein intake, vitamin D optimization, and estrogen therapy when appropriate remain far more effective tools for preserving musculoskeletal health.

What Is “Normal” Testosterone for Women?

There is no single “normal” testosterone range that applies to all women. Levels vary based on age, menstrual status, ovarian function, body composition, medication use, and SHBG levels.

Testosterone also fluctuates across the menstrual cycle. Because of this variability, symptoms and functional outcomes matter more than numbers alone. At My V Clinic in Thornton, hormone testing is used to support clinical decisions — not to chase arbitrary lab targets.

What Clinical Guidelines Actually Recommend

Major international guidelines agree on one key point: testosterone therapy for women should be limited and specific.

The Global Consensus Position Statement on Testosterone Therapy for Women recommends testosterone only for postmenopausal women with diagnosed HSDD, after other contributing factors have been addressed.

The International Society for the Study of Women’s Sexual Health allows cautious consideration in late reproductive-age and perimenopausal women, but does not endorse routine use.

Routine testosterone therapy for all menopausal women is not evidence-based.

Testosterone Therapy Options for Women

When testosterone therapy is appropriate, dosing must remain physiologic.

Options include:

• Transdermal creams or gels formulated for women

• Carefully dosed compounded preparations

Injectable testosterone and pellets may produce unpredictable or excessively high levels. Pellet therapy, in particular, has been associated with supraphysiologic exposure early after insertion and is difficult to reverse if side effects occur.

Risks and Monitoring

Potential side effects of testosterone therapy include:

• Acne

• Increased facial or body hair

• Scalp hair thinning

• Voice changes (rare, dose-related)

• Clitoral enlargement (rare, typically with excessive dosing)

Long-term safety data in women is still evolving. Testosterone therapy requires ongoing monitoring, symptom reassessment, and dose adjustment.

The Bottom Line for Women in Thornton, CO

Not all women need testosterone in menopause.

Testosterone can be beneficial for specific symptoms, particularly low sexual desire, in carefully selected patients. It is not a universal therapy, not an anti-aging solution, and not a replacement for comprehensive lifestyle and hormone care.

At My V Clinic, our goal is clarity — not pressure — so women in Thornton can make informed decisions rooted in science, safety, and long-term health.

General Information Disclaimer

This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Hormone therapy decisions should be made in consultation with a qualified healthcare provider based on individual medical history, symptoms, laboratory data, and personal goals.